## Abstract The outcome of 171 children with ALL who relapsed for the first time after elective cessation of therapy (1β86 mo) and followed over 10 years (median 60 mo; range 1β232 mo) has been evaluated. One hundred and three patients relapsed in the bone marrow (BM), 29 in the testis (T), 21 in t
Recovery of immune function after cessation of maintenance therapy in acute lymphoblastic leukemia (ALL) of childhood
β Scribed by G. A. M. Vaan; P. J. J. Munster; J. A. J. M. Bakkeren
- Publisher
- Springer
- Year
- 1982
- Tongue
- English
- Weight
- 573 KB
- Volume
- 139
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The results of cessation of therapy (COT) in 64 longβterm survivors (diseaseβfree survival of five years or more) of acute lymphoblastic leukemia (ALL) were analyzed to determine the incidence of relapse off therapy. Thirtyβseven of the patients had intermittent central nervous system (
Cyclic combination chemotherapy was administered to 26 patients with acute lymphoblastic leukemia who had relapsed in the bone marrow greater than or equal to 6 months after elective cessation of therapy. Each patient had been in initial continuous complete remission for 36-111 months (median, 47 mo
## Abstract We investigated liver function in 27 children with acute lymphocytic leukemia (ALL) after cessation of therapy. Induction therapy consisted of prednisolone + vincristine (VP regimen) alone (16 patients) or with addition of daunorubicin (4 patients) or Lβasparaginase (7 patients). Patien